pyrroles and azd4547
pyrroles has been researched along with azd4547 in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Balek, L; Buchtova, M; Dosedelova, H; Gudernova, I; Jelinkova, I; Kozubik, A; Krejci, P; Kunova, M; Pivnicka, J; Roubalova, L; Vesela, I | 1 |
| Castro, P; Coleman, I; Davies, BR; Feng, S; Ittmann, M; Nelson, PS; Shao, L; Smith, PD | 1 |
| Bruegger, DE; Hoover, L; Jones, JW; Le, T; New, J; Tawfik, O; Thomas, SM; Usman, S; Yalamanchali, S | 1 |
| Chen, Y; Feng, D; Jiang, R; Li, G; Liu, S; Peng, R; Wei, L; Zheng, S | 1 |
Other Studies
4 other study(ies) available for pyrroles and azd4547
| Article | Year |
|---|---|
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes.
Topics: Achondroplasia; Animals; Benzamides; Cartilage; Catalysis; Cells, Cultured; Chick Embryo; Chondrocytes; Humans; Mice; Phenylurea Compounds; Piperazines; Pyrazoles; Pyrimidines; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Signal Transduction; Syndrome | 2016 |
Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Humans; Male; Mice, SCID; Phosphorylation; Piperazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; STAT3 Transcription Factor; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma.
Topics: Angiofibroma; Antineoplastic Agents; Benzamides; Cell Movement; Cell Proliferation; Cells, Cultured; Fibroblasts; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Nasopharyngeal Neoplasms; Piperazines; Pyrazoles; Pyrroles; Receptors, Fibroblast Growth Factor; Receptors, Vascular Endothelial Growth Factor | 2017 |
Resistance to FGFR1-targeted therapy leads to autophagy via TAK1/AMPK activation in gastric cancer.
Topics: Adenocarcinoma; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Autophagy; Benzamides; Cell Culture Techniques; Cell Line, Tumor; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Humans; MAP Kinase Kinase Kinases; Mice; Mice, Inbred BALB C; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Stomach Neoplasms | 2020 |